Mariam Naveed1, Nisa Kubiliun2,3. 1. Department of Internal Medicine, University of Iowa Hospital and Clinics, Iowa City, USA. 2. Department of Internal Medicine, UT Southwestern Medical Center, Dallas, USA. nisa.kubiliun@utsouthwestern.edu. 3. Division of Digestive and Liver Diseases, University of Texas Southwestern, 1801 Inwood Road, Suite 6.102, Dallas, TX, 75390-9083, USA. nisa.kubiliun@utsouthwestern.edu.
Abstract
PURPOSE OF REVIEW: Esophageal cancer is a leading cause of global cancer-related mortality. Here, we discuss the major endoscopic treatment modalities for management of early esophageal cancer (EEC). RECENT FINDINGS: Advances in endoscopic imaging and therapy have shifted the paradigm of managing early esophageal cancers. Though esophagectomy remains the preferred management for advanced cancers, guidelines now recommend endoscopic resection followed by ablative therapy for early (Tis and T1a) cancers. Available data suggests endoscopic treatment is comparable to surgery with regard to overall and cancer-specific survival with lower procedural morbidity and mortality. Endoscopic modalities are emerging as frontline treatment options for patients with early esophageal cancers. Accurate clinical staging with assessment of disease extent, tumor grade, and risk of nodal metastases is crucial when determining eligibility for endoscopic management of EEC. High-quality routine surveillance endoscopy is critical in patients who have undergone resection and/or ablation.
PURPOSE OF REVIEW: Esophageal cancer is a leading cause of global cancer-related mortality. Here, we discuss the major endoscopic treatment modalities for management of early esophageal cancer (EEC). RECENT FINDINGS: Advances in endoscopic imaging and therapy have shifted the paradigm of managing early esophageal cancers. Though esophagectomy remains the preferred management for advanced cancers, guidelines now recommend endoscopic resection followed by ablative therapy for early (Tis and T1a) cancers. Available data suggests endoscopic treatment is comparable to surgery with regard to overall and cancer-specific survival with lower procedural morbidity and mortality. Endoscopic modalities are emerging as frontline treatment options for patients with early esophageal cancers. Accurate clinical staging with assessment of disease extent, tumor grade, and risk of nodal metastases is crucial when determining eligibility for endoscopic management of EEC. High-quality routine surveillance endoscopy is critical in patients who have undergone resection and/or ablation.
Entities:
Keywords:
Early esophageal cancer (EEC); Endoscopic mucosal resection (EMR); Endoscopic submucosal dissection (ESD); Esophageal adenocarcinoma (EAC); Esophageal squamous cell cancer (ESCC); Radio frequency ablation (RFA)
Authors: Thomas W Rice; Hemant Ishwaran; Mark K Ferguson; Eugene H Blackstone; Peter Goldstraw Journal: J Thorac Oncol Date: 2016-10-31 Impact factor: 15.609
Authors: Hendrik Manner; Oliver Pech; Yvonne Heldmann; Andrea May; Michael Pauthner; Dietmar Lorenz; Annette Fisseler-Eckhoff; Manfred Stolte; Michael Vieth; Christian Ell Journal: Surg Endosc Date: 2014-10-08 Impact factor: 4.584
Authors: Lorenza Alvarez Herrero; Frederike G I van Vilsteren; Roos E Pouw; Fiebo J W ten Kate; Mike Visser; Cornelis A Seldenrijk; Mark I van Berge Henegouwen; Paul Fockens; Bas L A M Weusten; Jaques J G H M Bergman Journal: Gastrointest Endosc Date: 2011-02-02 Impact factor: 9.427
Authors: Sarina Pasricha; William J Bulsiewicz; Kelly E Hathorn; Srinadh Komanduri; V Raman Muthusamy; Richard I Rothstein; Herbert C Wolfsen; Charles J Lightdale; Bergein F Overholt; Daniel S Camara; Evan S Dellon; William D Lyday; Atilla Ertan; Gary W Chmielewski; Nicholas J Shaheen Journal: Clin Gastroenterol Hepatol Date: 2014-05-09 Impact factor: 11.382
Authors: Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale Journal: N Engl J Med Date: 2009-05-28 Impact factor: 91.245
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: H Y Wang; X Zeng; S Y Bai; K Pu; Y Zheng; R Ji; Q H Guo; Q L Guan; Y P Wang; Y N Zhou Journal: Ann R Coll Surg Engl Date: 2020-08-21 Impact factor: 1.891